The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "Opioid abuse"

Search results for: Opioid abuse

How to Address Opioid Abuse with Patients

December 2, 2019 • By Carina Stanton

More than half of regular opioid users suffer from arthritis. Here are three tips to talk to your patients about opioid use and alternative pain management…... [Read More]

Filed Under: Drug Updates, Safety Tagged With: Opioid abuse, opioid alternatives, Pain Management, patient communication, physician-patient communication

Trump Declares National Emergency on Opioid Abuse

August 10, 2017 • By James Oliphant

BEDMINSTER, N.J. (Reuters)—U.S. President Donald Trump on Thursday declared the opioid epidemic a national emergency and said his administration was drafting papers to make it official. “The opioid crisis is an emergency and I’m saying officially right now it is an emergency,” Trump told reporters in New Jersey. “We’re going to draw it up and… [Read More]

Filed Under: Drug Updates Tagged With: national emergency, opioid crisis, opioid epidemic

Physicians Asked to Join AMA Efforts to Reduce Opioid Abuse

October 31, 2016 • By Mary Beth Nierengarten

In 2014, the American College of Rheumatology (ACR) was one of 25 healthcare associations invited to participate in an initiative by the American Medical Association (AMA) to reduce the public health epidemic posed by the abuse of prescription opioids.1 The AMA initiative is based on the belief that physicians are professionally obligated to participate in… [Read More]

Filed Under: Ethics, Professional Topics Tagged With: American Medical Association (AMA), Opioid abuse, opioid use disorders, Prescription drugs, substance abuse disorders, task force

FDA Sets Stricter Requirements for Immediate-Release Opioids to Prevent Misuse & Abuse

October 27, 2017 • By Michele B. Kaufman, PharmD, BCGP

The FDA is expanding its Risk Evaluation and Mitigation Strategy (REMS) to include manufacturers of immediate-release opioids. The makers of these drugs will soon be required to provide training and education to healthcare professionals on the proper prescription and use of the drugs for pain management…... [Read More]

Filed Under: Analgesics, Drug Updates Tagged With: FDA, opioid, Opioid abuse, REMS, U.S. Food and Drug Administration (FDA)

FDA Update: Committees Recommend Approvals for Abuse-Deterrent Opioid & Brodalumab

August 17, 2016 • By Michele B. Kaufman, PharmD, BCGP

FDA advisory committees recommend the approvals of the abuse-deterrent opioid morphine sulfate for pain and brodalumab for plaque psoriasis…... [Read More]

Filed Under: Analgesics, Biologics & Biosimilars, Drug Updates Tagged With: brodalumab, FDA, Food and Drug Administration, morphine sulfate, Opioids, Pain, plaque psoriasis

Most Seniors Won’t Abuse Opioids After Surgery

August 13, 2016 • By Andrew M. Seaman

(Reuters Health)—Seniors who receive prescriptions for opioid drugs to control pain after major surgery don’t usually end up addicted to them, research from Canada shows. One year after having major surgery, less than 1% of patients over age 66 were still taking opioids, according to a report in JAMA Surgery. Recent research has suggested the… [Read More]

Filed Under: Analgesics, Drug Updates Tagged With: Addiction, elderly, Opioids, Pain, Pain Management, senior, surgery

U.S. Panel Backs Approval of Abuse-Resistant Opioid Painkiller

August 7, 2016 • By Reuters Staff

WASHINGTON (Reuters)—A U.S. advisory panel on Thursday recommended approval of Egalet Corp’s long-acting opioid painkiller, Arymo ER (morphine sulfate), saying it dulls pain and could deter abuse by addicts seeking a quick high. The panel recommended that the U.S. Food and Drug Administration (FDA) approve the drug and said it deters, but does not eliminate,… [Read More]

Filed Under: Analgesics, Drug Updates Tagged With: abuse, Addiction, Drugs, FDA, Food and Drug Administration, Opioids

FDA Panel Backs Teva’s Abuse-Resistant Opioid Painkiller

June 8, 2016 • By Natalie Grover & Toni Clarke

(Reuters)—A U.S. Food and Drug Administration (FDA) advisory panel recommended approving Teva Pharmaceuticals Industries Ltd’s long-acting opioid painkiller, Vantrela ER, saying data showed it reduces pain and has some abuse-resistant properties. The drug is designed for use every 12 hours for the management of pain severe enough to require around-the-clock treatment in patients who have… [Read More]

Filed Under: Analgesics, Drug Updates Tagged With: Chronic pain, FDA, Food and Drug Administration, Opioids, Teva Pharmaceuticals

Speak Out Rheum: How Did We Go So Wrong with Opioid Prescribing?

November 4, 2022 • By Richard Brasington Jr., MD, FACP, MACR

I have been listening to The Fighter Pilot Podcast because my fantasy career would have been to fly a jet fighter plane (not even remotely possible, given my constitution). I learned that when an aircraft accident occurs, a mishap board is convened, not to assign blame but to try to learn what went wrong and… [Read More]

Filed Under: Analgesics, Drug Updates, Opinion Tagged With: opioid crisis, Speak Out Rheumatology

Are Opioid Contracts Helpful or Harmful?

October 18, 2019 • By Steven M. Harris, Esq.

The opioid epidemic in the U.S. has destroyed thousands of lives and torn families apart. According to the Centers for Disease Control and Prevention, an average of 130 people in the U.S. die each day from an opioid overdose. From 1999 to 2017, more than 700,000 died as a result of drug overdoses. In 2017,… [Read More]

Filed Under: Legal Tagged With: opioid contracts, opioid crisis, physician patient relationship

  • 1
  • 2
  • 3
  • …
  • 12
  • Next Page »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)